New research suggests that men who take multivitamins after being diagnosed with prostate cancer may have a lower risk of cancer recurrence. In the overall study group, current multivitamin users ...

Cannabis each day keeps prostate cancer away: Prostate cancer (PC) prevalence was lower in both current and former cannabis users compared to non-users in a recent study. Alternative medicines are ...

An FDA advisory panel has voted 7-1, with one abstention, to recommend expanding the use of AstraZeneca’s capivasertib (Truqap) for PTEN-deficient metastatic hormone-sensitive prostate cancer. The ...

ORLANDO—Statin use is associated with a nearly two thirds reduced risk of death from prostate cancer, a study found. The finding is based on a study of 760 New Jersey men—380 cases (men aged 55-79 who ...

Los Angeles, Calif. – Testosterone therapy does not cause adverse effects on the prostate in older men with hypogonadism, commonly known as low testosterone or low T, according to a clinical trial ...

XTANDI is now the first and only novel hormone therapy available for the treatment of high-risk biochemical recurrent non-metastatic hormone-sensitive prostate cancer in the European Union (EU) XTANDI ...